The pharmaceutical trade between India and North Macedonia has experienced steady growth over recent years. In 2024, India's pharmaceutical exports to North Macedonia were valued at approximately $5.73 million, marking a significant increase from previous years. This upward trajectory underscores the strengthening commercial ties between the two nations.
The primary products exported include finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. Notably, in 2024, the top export was Pharma Foxero Cefpodoxime Tablets 200mg, accounting for 60.4% of the total export value. Other significant exports include Massido 5 mg Tablets and Tridox 40mg 5ml Suspension, reflecting India's capacity to meet North Macedonia's diverse pharmaceutical needs.
The trade is facilitated through key Indian export ports, including Bombay Air Cargo, Ahmedabad Air, and Delhi Air Cargo, with Delhi Air Cargo handling the majority of shipments. All imports arrive at Skopje, the capital of North Macedonia, indicating a streamlined logistics process. The regulatory framework in North Macedonia, governed by the National Drug Regulatory Authority (WHO-GMP), ensures that imported pharmaceutical products adhere to stringent quality standards.
